Nea Management Company, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Nea Management Company, LLC
- $1.21 Billion
- Q2 2025
A detailed history of Nea Management Company, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 2,909,956 shares of RYTM stock, worth $288 Million. This represents 15.24% of its overall portfolio holdings.
Number of Shares
2,909,956
Previous 2,909,956
-0.0%
Holding current value
$288 Million
Previous $154 Million
19.29%
% of portfolio
15.24%
Previous 14.62%
Shares
3 transactions
Others Institutions Holding RYTM
# of Institutions
246Shares Held
64MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$666 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$554 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$550 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$482 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$355 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.51B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...